[
  {
    "id": "men1-syndrome_5880_1750166974.txt-1",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#definitiongeneral68678",
    "clean_content": "Definition / general\n\n* Syndrome characterized by mutations in *MEN1* gene and development of multiple endocrine tumors (and other tumor types)* Formerly known as Wermer syndrome* Autosomal dominant inheritance"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-2",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#essentialfeatures68679",
    "clean_content": "Essential features\n\n* Defined by *MEN1* mutation (chromosome 11q13, menin, tumor suppressor gene, 100% penetrance)* Classic constellation of pituitary, parathyroid and pancreatic tumors (the 3 P's)* Variety of nonendocrine tumors are also part of *MEN1* (meningioma, ependymoma, angiofibroma)"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-3",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#epidemiology68680",
    "clean_content": "Epidemiology\n\n* Prevalence of *MEN1* is 1:30,000 to 1:500,000 (geographic variability due to familial clustering) ([F1000Res 2017;6:73](28184288))* *MEN1* cases are 90% familial and 10% sporadic ([F1000Res 2017;6:73](28184288))* 100% penetrance (100% with parathyroid adenomas by age 50) ([F1000Res 2017;6:73](28184288))* Most frequent cause of *MEN1* related death is complications secondary to pancreatic / gastrointestinal neuroendocrine tumors ([J Pediatr Genet 2016;5:89](27617149))"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-4",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#sites68681",
    "clean_content": "Sites\n\n* Variety of neuroendocrine and nonneuroendocrine tumors ([J Pediatr Genet 2016;5:89](27617149), [Cancer Genet 2016;209:36](26767918), [Endocr Relat Cancer 2017;24:T119](28899949))\n\nEndocrine tumors found in:\n\n* Parathyroid (90% of patients)* Anterior pituitary (30 - 40% of patients)* Pancreas / gastrointestinal tract (30 - 70% of patients)* Adrenal cortex* Thymus\n\nNonendocrine tumors found in:\n\n* Facial skin (angiofibromas, collagenomas)* Testis (epididymomas)* Meninges (meningiomas)\n\n  \n\nOf note, nonsyndromic tumors have somatic *MEN1* mutations at the following frequencies ([Endocr Relat Cancer 2017;24:T119](28899949)):* Glucagonoma 60%* VIPoma 57%* Nonfunctioning PanNETs 44%* Gastrinoma 38%* Bronchial carcinoid 35%* Parathyroid adenoma 35%* Lipoma 28%* Insulinoma 2 - 19%* Angiofibroma 10%* Anterior pituitary tumor 3.5%* Adrenocortical tumor 2%"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-5",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#pathophysiology68682",
    "clean_content": "Pathophysiology\n\n* *MEN1* gene first identified in 1997, found on chromosome 11q13 ([Science 1997;276:404](9103196))* Menin, the protein product of *MEN1*, is a tumor suppressor gene* Twelve mutations were initially identified and more than 1,800 mutations have been identified to date* Most of these are private (family specific)* Seventy five percent are inactivating ([F1000Res 2017;6:73](28184288))* 5 - 20% may not harbor mutations in the *MEN1* gene coding region ([F1000Res 2017;6:73](28184288), [Cancer Genet 2016;209:36](26767918))* There is no genotype phenotype correlation with the type of *MEN1* mutation and the type of tumors which develop ([F1000Res 2017;6:73](28184288))* Menin does not show homology with any other known protein but is conserved across species from *Drosophila* to humans ([F1000Res 2017;6:73](28184288), [Cancer Genet 2016;209:36](26767918))* Normal functions of menin: cell proliferation, apoptosis and genome integrity ([F1000Res 2017;6:73](28184288))* Mechanism by which a nonfunctional menin protein causes tumor development remains unknown"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-6",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagrams / tables",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#diagramstables68683",
    "clean_content": "Diagrams / tables\n\nImages hosted on other servers:  \n\n[![Missing Image](https://www.pathologyoutlines.com/thumb/pancreasMEN1diagram1.jpg)](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574000/figure/F1/)\n\nLocation of tumors in patients with *MEN1*"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-7",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#clinicalfeatures68684",
    "clean_content": "Clinical features\n\n* Endocrine tumors found in parathyroid, anterior pituitary, pancreas / gastrointestinal tract, adrenal cortex and thymus* Non endocrine tumors: angiofibromas, collagenomas, epididymomas, meningiomas* Increased frequency of renal stones compared with the general population* Penetrance is 100%, with all patients developing parathyroid adenomas by age 50* Patients with gastrinomas, typically found in the duodenum, may have Zollinger-Ellison syndrome* Primary gastrinomas may be microadenomas but the lymph node metastases can be much larger than the primary ([J Pediatr Genet 2016;5:89](27617149))* Patients with parathyroid adenomas have hypersecretion of parathyroid hormone (PTH) with resultant symptoms of hypercalcemia (GI pain, renal stones, clouded mental functioning)* Cushing disease, Nelson syndrome, acromegaly or hyperprolactinemia in cases of functional pituitary adenomas* Pituitary adenomas can also cause a number of visual field defects due to compression of the optic chiasm or extraocular muscle compression* Syndromes of other functioning pancreatic and gastrointestinal neuroendocrine neoplasms can be found on [Neuroendocrine Neoplasms - General](https://www.pathologyoutlines.com/topic/pancreaspen.html)"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-8",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#diagnosis68685",
    "clean_content": "Diagnosis\n\n* Identification of a *MEN1* mutation by PCR amplification of exons and splicing sites\n  + Notably, this fails to identify the subset of *MEN1* patients that do not have the mutation within the coding region ([World J Exp Med 2015;5:124](25992327))+ Next generation sequencing would bypass these limitations* Mutational analysis should be offered to:\n    + Asymptomatic first degree relatives of a known *MEN1* patient+ Patients with at least two typical *MEN1* tumors or one *MEN1* tumor and a positive family history+ Patients with early onset (< 30 years) of a typical *MEN1* manifestation (hyperparathyroidism, Zollinger-Ellison syndrome) ([Endocr Relat Cancer 2017;24:T209](28790162))"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-9",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#laboratory68686",
    "clean_content": "Laboratory\n\n* Relevant to the type of tumor present and only functional tumors"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-10",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#radiologydescription68687",
    "clean_content": "Radiology description\n\n* Osteoporosis, terminal tuft erosion (distal phalanges) and nephrolithiasis in patients with parathyroid adenomas and hypercalcemia* Calvarial thickening, frontal bossing, enlarged sinuses (especially frontal sinuses), enlarged sella turcica, prognathic mandible and increased vertebral fractures in patients with acromegaly due to pituitary adenoma"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-11",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#prognosticfactors68688",
    "clean_content": "Prognostic factors\n\n* As described for pancreatic and gastrointestinal tumors in the [WHO classification](https://www.pathologyoutlines.com/topic/pancreaswho.html)"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-12",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#casereports68689",
    "clean_content": "Case reports\n\n* 18 year old woman with hyperprolactinemia and hypercalcemia since age 13 ([Clinical Chemistry 2015;61:1328](http://clinchem.aaccjnls.org/content/61/11/1328.long))* 36 year old man with pancreatic neuroendocrine tumor, pituitary adenoma and acromegaly ([W V Med J 2012;108:26](22655432))* 51 year old man with urolithiasis and 2 jejunal perforations 9 months apart ([Korean J Gastroenterol 2013;61:333](http://pdf.medrang.co.kr/Kjg/061/Kjg061-06-07.pdf))"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-13",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#treatment68690",
    "clean_content": "Treatment\n\n* Surgical resection of neuroendocrine tumors* Minimally invasive trans sphenoidal approach for pituitary adenomas* Increased screening and surveillance in known kindreds: insulinoma starting age 5, pituitary adenoma starting age 5, parathyroid adenoma starting age 8, gastrinoma starting age 20, adrenal gland starting before age 10, thymic tumors starting before age 15 ([World J Exp Med 2015;5:124](25992327))"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-14",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#grossimages68691",
    "clean_content": "Gross images\n\nAFIP images  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1AFIPgross1.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1AFIPgross1.jpg)\n\nIntramucosal tumor nodules\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1AFIPgross2.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1AFIPgross2.jpg)\n\nZollinger-Ellison syndrome"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-15",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#microscopichistologicimages68692",
    "clean_content": "Microscopic (histologic) images\n\nAFIP images  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP1.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP1.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP2.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP2.jpg)\n\nPancreatic microadenomas in patients with MEN1\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP3.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP3.jpg)\n\nDuodenal gastrinoma in the mucosa and submucosa\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP4.jpg)](https://www.pathologyoutlines.com/imgau/pancreasMEN1microAFIP4.jpg)\n\nHypertrophic and eroded mucosa"
  },
  {
    "id": "men1-syndrome_5880_1750166974.txt-16",
    "source_document": "men1-syndrome_5880_1750166974.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasMEN1.html#molecularcytogeneticsdescription68693",
    "clean_content": "Molecular / cytogenetics description\n\n* *MEN1* mutation (chromosome 11q13)"
  }
]